STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Correction of the release dated April 17, 2014
Financière de l'Echiquier, Paris, France has notified us pursuant to sec.
21 para. 1 WpHG on 3 June 2014, that on 16 April 2014 the share of voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001
went below the threshold of 3% and that the percentage of voting rights on
that day amounted to 2.96% (348,851 voting rights). Of these, 0.29% (34,000
voting rights) are attributable to the company pursuant to sec. 22 para 1
sent. 1 no. 6 WpHG.
04.06.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Company: STRATEC Biomedical AG
End of Announcement DGAP News-Service